Dental Pulp Exposure Clinical Trial
Official title:
Efficacy of Er,Cr:YSGG Laser Irradiation Combined With Resin Based Tricalcium Silicate and Calcium Hydroxide on Direct Pulp Capping: a Randomized Clinical Trial
The purpose of this randomized clinical study was to evaluate the efficiency of Er,Cr:YSGG laser irradiation combined with a resin based tricalcium silicate material and calcium hydroxide (CH) in direct pulp capping for 3 months follow-up period.Sixty permanent vital teeth without symptoms and radiographic changes were randomly assigned to 4 groups (n=15): Gr 1: The exposed area was sealed with CH paste, Gr 2: The treated area was sealed with CH paste following Er,Cr:YSGG laser irradiation at an energy level of 0,5 W without water and 45% air, Gr 3: Resin based tricalcium silicate material (TheraCal LC) was applied directly to the exposed pulp, Gr 4: TheraCal LC was applied following irradiation with Er,Cr:YSGG laser.
CH is used as gold standard in pulp capping procedures due to its beneficial properties such
as induction of mineralization and inhibition of bacterial growth; however tunnel defects
and cell inclusions in dentin bridges formed by CH may lead to leakage and bacteria
penetration resulting in loss of vitality.
TheraCal LC is a new light-cured, resin-modified, tricalcium silicate based material
designed to use for direct and indirect pulp-capping aiming to achieve a bond to composite
resins thus reducing micro-leakage.The formulation of TheraCal LC containing tricalcium
silicate particles in a hydrophilic monomer provides significant calcium release that
stimulates hydroxyapatite and secondary dentin bridge formation The use of laser for direct
pulp capping has been suggested for the considerable advantages of lasers including
decontamination effect, biostimulation effect, hemostatic and coagulant effect.The erbium,
chromium-doped:yttrium, scandium, gallium and garnet (Er,Cr:YSGG) laser which is a
relatively new device has been reported to ablate dental hard tissues thanks to its high
absorption in water and also strong absorption by the hydroxyl radicals present in the
hydroxyapatite structure
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02019563 -
MTA/FS Pulpotomy for Vital Primary Incisors: A Randomized Controlled Trial
|
Phase 2 | |
Completed |
NCT00812877 -
Pulp Capping With Two Different Agents
|
N/A | |
Not yet recruiting |
NCT04330768 -
Platelet Rich Fibrin(PRF) Injection for Treatment of Dental Pulp Exposure:Randomized Clinical Trial
|
N/A | |
Completed |
NCT02789423 -
Clinical & Radiographical Evaluation of the Effect of Dycal & Biodentine in DPC in Primary Teeth
|
N/A | |
Completed |
NCT01468480 -
Human Pulpal Response After Pulp Capping With Four Different Agents
|
Phase 2/Phase 3 | |
Completed |
NCT00187850 -
The CAP-2 Trial: Effect of Direct Pulp Capping Versus Partial Pulpotomy
|
N/A | |
Completed |
NCT03631511 -
Histological Evaluation of Hard Tissue Formation After Direct Pulp Capping With RetroMTA
|
N/A | |
Completed |
NCT02492841 -
Calcium Hydroxide, Mineral Trioxide Aggregate and Biodentine (Trademark) as Direct Pulp Capping of Permanent Teeth
|
Phase 2/Phase 3 |